Nyxoah SA (NYXH) News
Filter NYXH News Items
NYXH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NYXH News Highlights
- For NYXH, its 30 day story count is now at 7.
- Over the past 16 days, the trend for NYXH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- AMP, SA and OSA are the most mentioned tickers in articles about NYXH.
Latest NYXH News From Around the Web
Below are the latest news stories about NYXOAH SA that investors may wish to consider to help them evaluate NYXH as an investment opportunity.
Nyxoah S.A. (NYXH) Q1 2023 Earnings Call TranscriptNyxoah S.A. (NYXH) Q1 2023 Earnings Conference Call May 16, 2023 16:30 ET Corporate Participants Mikaela Kirkwood - Corporate Communications and Investor Relations Manager Olivier Taelman - Chief Executive Officer Loic Moreau - Chief Financial Officer Conference Call Participants Jon Block - Stifel Adam Maeder - Piper Sandler Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer Presentation Operator Thank you for standing by, and welcome to Nyxoah's First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [... |
Nyxoah S.A. (NASDAQ:NYXH) Q1 2023 Earnings Call TranscriptNyxoah S.A. (NASDAQ:NYXH) Q1 2023 Earnings Call Transcript May 16, 2023 Nyxoah S.A. beats earnings expectations. Reported EPS is $-0.29, expectations were $-0.34. Operator: Thank you for standing by, and welcome to Nyxoah’s First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will […] |
Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue EstimatesNyxoah SA (NYXH) delivered earnings and revenue surprises of -32.43% and 61.23%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
Nyxoah Reports First Quarter 2023 Financial and Operating ResultsREGULATED INFORMATION Nyxoah Reports First Quarter 2023 Financial and Operating Results Mont-Saint-Guibert, Belgium – May 16, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the first quarter of 2023. Recent Financial and Operating Highlights Completed |
Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023REGULATED INFORMATIONMay 12, 2023, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to Attend the Annual Shareholders’ Meeting of the Company to be Held on June 14, 2023 The board of directors of the Company is pleased to invite its securities holders to attend the annual shareholders' meeting of the Company, to be held on Wednesday, June 14, 2023 at 2:00 p.m. CET at the Company's seat, or at suc |
Nyxoah Appoints Christoph Eigenmann as Chief Commercial OfficerNyxoah Appoints Christoph Eigenmann as Chief Commercial Officer Mont-Saint-Guibert, Belgium – May 10, 2023, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Christoph Eigenmann as Chief Commercial Officer. Christoph will oversee commercial activities globally, be responsibl |
Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023 Mont-Saint-Guibert, Belgium – May 1, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter of 2023 on Tuesday, May 16, 2023, after market close. Compan |
Publication Relating to Transparency NotificationsREGULATED INFOMATION Publication Relating to Transparency Notifications Mont-Saint-Guibert (Belgium), April 20, 2023, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Together Partnership On April 18, 2023, Nyxoah received a transparency notification from Together Partnership following the crossing of the |
Information on the Total Number of Voting Rights and SharesREGULATED INFORMATION Information on the Total Number of Voting Rights and Shares Mont-Saint-Guibert (Belgium), April 17, 2023, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 4,923,807.45 Total number of securities carrying voting rights: 28,661,985 (all ordinary shares) Total number of v |
Strength Seen in Nyxoah SA (NYXH): Can Its 10.2% Jump Turn into More Strength?Nyxoah SA (NYXH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. |